Bioanalytical Systems, Inc. - Form 8K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported):  August 11, 2004




BIOANALYTICAL SYSTEMS, INC.
(Exact name of registrant as specified in its charter)

Indiana 0-23357 35-1345024
(State or other jurisdiction of
incorporation or organization)
(Commission File Number) (IRS Employer Identification No.)

2701 Kent Avenue
West Lafayette, Indiana

47906-1382
(Address of principal executive offices) (Zip Code)
(765) 463-4527
  (Registrant's telephone number, including area code)

        The information in this Form 8-K is being furnished and shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information in this Form 8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act.

Item 7.    Financial Statements and Exhibits.

        (a)         Not applicable.

        (b)         Not applicable.

        (c)         Exhibits

        99.1        Bioanalytical Systems, Inc. press release, issued August 11, 2004.

Item 12.    Results of Operations and Financial Condition

        On August 11, 2004, Bioanalytical Systems, Inc. issued a press release providing information on earnings and other financial results for its third quarter of fiscal 2004 ended June 30, 2004. The full text of the press release is furnished as Exhibit 99.1 to this Form 8-K.

SIGNATURES


        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.





Date:  August 11, 2004
Bioanalytical Systems, Inc.



By:  /s/ Michael R. Cox
Michael R. Cox
VP-Finance, Finance, Treasurer and
Chief Financial Officer

Exhibit Index

Exhibit No.

99.1
Description

Bioanalytical Systems, Inc. press release, issued August 11, 2004.